Gadofosveset-based biomarker of tissue albumin concentration: Technical validation in vitro and feasibility in vivo

Magnetic Resonance in Medicine

Volumn 73, Issue 1, 2015, Pages 244-253

  Richardson, Owen C ^a   Bane, Octavia ^b   Scott, Marietta L J ^c   Tanner, Steven F ^d   Waterton, John C ^c   Sourbron, Steven P ^a   Carroll, Timothy J ^b   Buckley, David L ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b NORTHWESTERN UNIVERSITY   (United States)

^c ASTRAZENECA   (United Kingdom)

^d LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Albumin; Binding; Biomarker; Gadofosveset; Relaxivity

Indexed keywords

CORRELATION METHODS; TISSUE;

ALBUMIN; BINDING; GADOFOSVESET; PATHOPHYSIOLOGIC; PEARSON CORRELATION COEFFICIENTS; RELAXATION MODELS; RELAXIVITY; THEORY AND METHODS;

BIOMARKERS;

ALBUMIN; GADOFOSVESET; GADOLINIUM PENTETATE MEGLUMINE; ALBUMINOID; BIOLOGICAL MARKER; CONTRAST MEDIUM; GADOLINIUM; ORGANOMETALLIC COMPOUND;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HEART LEFT VENTRICLE; HEART MUSCLE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; ANATOMY AND HISTOLOGY; BIOLOGICAL MODEL; CARDIAC MUSCLE; COMPUTER ASSISTED DIAGNOSIS; COMPUTER SIMULATION; EVALUATION STUDY; HEART; METABOLISM; MOLECULAR IMAGING; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; VALIDATION STUDY;

ADULT; ALBUMINS; BIOMARKERS; COMPUTER SIMULATION; CONTRAST MEDIA; FEASIBILITY STUDIES; FEMALE; GADOLINIUM; HEART; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MODELS, BIOLOGICAL; MOLECULAR IMAGING; MYOCARDIUM; ORGANOMETALLIC COMPOUNDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

EID: 84919837685     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.25128     Document Type: Article

References (61)

1. Doweiko JP, Nompleggi DJ. Role of albumin in human physiology and pathophysiology. J Parenter Enteral Nutr 1991;15:207-211.
2. Bhattacharya AA, Grune T, Curry S. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J Mol Biol 2000;303:721-732.
3. Kratochwil NA, Huber W, Muller F, Kansy M, Gerber PR. Predicting plasma protein binding of drugs: a new approach. Biochem Pharmacol 2002;64:1355-1374.
4. Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth 2000;85:599-610.
5. Bradley J, Cunningham K, Jackson V. Serum protein levels in critically ill surgical patients. Intensive Care 1981;7:291-295.
6. Djousse L, Rothman KJ, Cupples LA, Levy D, Ellison RC. Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham offspring study. Circulation 2002;106:2919-2924.
7. Ballmer PE. Causes and mechanisms of hypoalbuminaemia. Clin Nutr 2001;20:271-273.
8. Saeed M, Van Dijke CF, Mann JS, Wendland MF, Rosenau W, Higgins CB, Brasch RC. Histologic confirmation of microvascular hyperpermeability to macromolecular MR contrast medium in reperfused myocardial infarction. J Magn Reson Imaging 1998;8:561-567.
9. Seitz RJ, Wechsler W. Immunohistochemical demonstration of serum proteins in human cerebral gliomas. Acta Neuropathol 1987;73:145-152.
10. Poulsen HL. Subcutaneous interstitial fluid albumin concentration in long-term diabetes-mellitus. Scand J Clin Lab Invest 1973;32:167-173.
11. Haaverstad R, Romslo I, Larsen S. Protein concentration of subcutaneous interstitial fluid in the human leg. J Vasc Res 1996;16:111-117.
12. Ellmerer M, Schaupp L, Brunner GA, Sendlhofer G, Wutte A, Wach P, Pieber TR. Measurement of interstitial albumin in human skeletal muscle and adipose tissue by open-flow microperfusion. Am J Physiol Endocrinol Metab 2000;278:E352-E356.
13. Waterton JC. Translational magnetic resonance imaging and spectroscopy: opportunities and challenges. In: Garrido L, Beckmann N, editors. New applications of NMR in drug discovery and development. Cambridge, UK: RSC press; 2013. p 333-360.
14. Daldrup H, Shames DM, Wendland M, Okuhata Y, Link TM, Rosenau W, Lu Y, Brasch RC. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. AJR Am J Roentgenol 1998;171:941-949.
15. Roberts TPL, Turetschek K, Preda A, Novikov V, Moeglich M, Shames DM, Brasch RC, Weinmann HJ. Tumor microvascular changes to anti-Angiogenic treatment assessed by MR contrast media of different molecular weights. Acad Radiol 2002;9(Suppl. 2):S511-S513.
16. Schwitter J, Saeed M, Wendland MF, Derugin N, Canet E, Brasch RC, Higgins CB. Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadoliniumbased magnetic resonance contrast agents. J Am Coll Cardiol 1997;30:1086-1094.
17. Aime S, Caravan P. Biodistribution of gadolinium-based contrast agents, including gadolinium deposition. J Magn Reson Imaging 2009;30:1259-1267.
18. Lauffer RB, Parmelee DJ, Dunham SU, Ouellet HS, Dolan RP, Witte S, McMurry TJ, Walovitch RC. MS-325: albumin-targeted contrast agent for MR angiography. Radiology 1998;207:529-538.
19. Barrett T, Kobayashi H, Brechbiel M, Choyke PL. Macromolecular MRI contrast agents for imaging tumor angiogenesis. Eur J Radiol 2006;60:353-366.
20. Bremerich J, Bilecen D, Reimer P. MR angiography with blood pool contrast agents. Eur Radiol 2007;17:3017-3024.
21. Puig J, Blasco G, Essig M, et al. Albumin-binding MR blood pool contrast agent improves diagnostic performance in human brain tumour: comparison of two contrast agents for glioblastoma. Eur Radiol 2012:1-9.
22. Milot L, Haider M, Foster L, McGregor C, Law C. Gadofosveset trisodium in the investigation of focal liver lesions in noncirrhotic liver: early experience. J Magn Reson Imaging 2012;36:738-742.
23. Thouet T, Schnackenburg B, Kokocinski T, Fleck E, Nagel E, Kelle S. Visualization of chronic myocardial infarction using the intravascular contrast agent MS-325 (Gadofosveset) in patients. Sci World J 2012:1-6.
24. Phinikaridou A, Andia ME, Protti A, Indermuchle A, Shah A, Smith A, Warley A, Botnar RM. Noninvasive magnetic resonance imaging evaluation of endothelial permeability in murine atherosclerosis using an albumin-binding contrast agent. Circulation 2012;126:707-719.
25. Leporq B, Dumortier J, Pilleul F, Beuf O. 3D-liver perfusion MRI with the MS-325 blood pool agent: A noninvasive protocol to asses liver fibrosis. J Magn Reson Imaging 2012;35:1380-1387.
26. Richardson OC, Scott MLJ, Tanner SF, Waterton JC, Buckley DL. Overcoming the low relaxivity of gadofosveset at high field with spin locking. Magn Reson Med 2012;68:1234-1238.
27. Eldredge HB, Spiller M, Chasse JM, Greenwood MT, Caravan P. Species dependence on plasma protein binding and relaxivity of the gadolinium-based MRI contrast agent MS-325. Invest Radiol 2006;41:229-243.
28. Caravan P, Cloutier NJ, Greenfield MT, et al. The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. J Am Chem Soc 2002;124:3152-3162.
29. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann H-J. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005;40:715-724.
30. Muller RN, Raduchel B, Laurent S, Platzek J, Pierart C, Mareski P, Vander Elst L. Physicochemical characterization of MS-325, a new gadolinium complex, by multinuclear relaxometry. Eur J Inorg Chem 1999;1999:1949-1955.
31. Aime S, Fasano M, Terreno E, Botta M. Protein-bound metal chelates. In: Merbach AE, Toth E, editors. The chemistry of contrast agents in medical magnetic resonance imaging. Chichester: John Wiley & Sons; 2001. p 193-242.
32. Port M, Corot C, Violas X, Robert P, Raynal I, Gagneur G. How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo. Invest Radiol 2005;40:565-573.
33. Aime S, Chiaussa M, Digilio G, Gianolio E, Terreno E. Contrast agents for magnetic resonance angiographic applications: 1H and 17O NMR relaxometric investigations on two gadolinium (III) DTPA-like chelates endowed with high binding affinity to human serum albumin. J Biol Inorg Chem 1999;4:766-774.
34. Caravan P, Farrar CT, Frullano L, Uppal R. Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents. Contrast Media Mol Imaging 2009;4:89-100.
35. Hennig J, Nauerth A, Friedburg H. RARE imaging: a fast imaging method for clinical MR. Magn Reson Med 1986;3:823-833.
36. Henkelman RM. Measurement of signal intensities in the presence of noise in MR images. Med Phys 1985;12:232-233.
37. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004;52:141-146.
38. Xue H, Shah S, Greiser A, Guetter C, Littmann A, Jolly M-P, Arai AE, Zuehlsdorff S, Guehring J, Kellman P. Motion correction for myocardial T1 mapping using image registration with synthetic image estimation. Magn Reson Med 2012;67:1644-1655.
39. Giri S, Chung YC, Merchant A, Mihai G, Rajagopalan S, Raman SV, Simonetti OP. T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson 2009;11:56.
40. Wang Y, Spiller M, Caravan P. Evidence for weak protein binding of commercial extracellular gadolinium contrast agents. Magn Reson Med 2010;63:609-616.
41. Bagher-Ebadian H, Paudyal R, Nagaraja TN, Croxen RL, Fenstermacher JD, Ewing JR. MRI estimation of gadolinium and albumin effects on water proton. Neuroimage 2011;54(Suppl. 1):S176-S179.
42. Pedersen SF, Thrysoe SA, Paaske WP, Thim T, Falk E, Ringgaard S, Kim WY. CMR Assessment of endothelial damage and angiogenesis in porcine coronary arteries using gadofosveset. J Cardiovasc Magn Reson 2011;13:10.
43. Biris O, Benefield B, Harris KR, Lee DC. A steady-state method for computation of myocardial blood volume with the intravascular contrast agent Ablavar. J Cardiovasc Magn Reson 2012;14(Suppl. 1):P49.
44. Makowski MR, Wiethoff AJ, Uribe S, et al. Congenital heart disease: Cardiovascular MR imaging by using an intravascular blood pool contrast agent. Radiology 2011;260:680-688.
45. Ritter CO, Wilke A, Wichmann T, Beer M, Hahn D, Kostler H. Comparison of intravascular and extracellular contrast media for absolute quantification of myocardial rest-perfusion using high-resolution MRI. J Magn Reson Imaging 2011;33:1047-1051.
46. Wagner M, Rosler R, Lembcke A, et al. Whole-heart coronary magnetic resonance angiography at 1.5 tesla: Does a blood-pool contrast agent improve diagnostic accuracy? Invest Radiol 2011;46:152-159.
47. Noeske R, Seifert F, Rhein KH, Rinneberg H. Human cardiac imaging at 3 T using phased array coils. Magn Reson Med 2000;44:978-982.
48. Zhao J, Clingman C, Narvainen M, Kauppinen R, van Zijl P. Oxygenation and hematocrit dependence of transverse relaxation rates of blood at 3T. Magn Reson Med 2007;58:592-597.
49. Zaman A, Higgins DM, Kouwenhoven M, Kidambi A, Greenwood JP, Plein S. Robust myocardial T2 and T2∗ mapping at 3T. J Cardiovasc Magn Reson 2012;14:(Suppl. 1): P306.
50. Stanisz GJ, Odrobina EE, Pun J, Escaravage M, Graham SJ, Bronskill MJ, Henkelman RM. T1, T2 relaxation and magnetization transfer in tissue at 3T. Magn Reson Med 2005;54:507-512.
51. Brasch RC. Rationale and applications for macromolecular Gd-based contrast agents. Magn Reson Med 1991;22:282-287.
52. Bane O, Lee DC, Benefield B, Markl M, Carr J, Carroll TJ. A pilot study of leakage and compartmentalization of the contrast agent Ablavar. J Cardiovasc Magn Reson 2013;15(Suppl. 1):E7.
53. Rothschild M, Oratz M, Schreiber S. Albumin synthesis. N Engl J Med 1972;286:748-757.
54. Fogh-Andersen N, Altura BM, Altura BT, Siggaardandersen O. Composition of interstitial fluid. Clin Chem 1995;41:1522-1525.
55. Kellman P, Wilson JR, Xue H, Bandettini WP, Shanbhag SM, Druey KM, Ugander M, Arai AE. Extracellular volume fraction mapping in the myocardium, part 2: Initial clinical experience. J Cardiovasc Magn Reson 2012;14:64.
56. Broadbent DA, Biglands JD, Larghat A, Sourbron SP, Radjenovic A, Greenwood JP, Plein S, Buckley DL. Myocardial blood flow at rest and stress measured with dynamic contrast-enhanced MRI: Comparison of a distributed parameter model with a Fermi function model. Magn Reson Med 2013;70:1591-1597.
57. Pickup S, Wood AK, Kundel HL. Gadodiamide T1 relaxivity in brain tissue in vivo is lower than in saline. Magn Reson Med 2005;53:35-40.
58. Notohamiprodjo M, Pedersen M, Glaser C, Helck AD, Lodemann K-P, Jespersen B, Fischereder M, Reiser MF, Sourbron SP. Comparison of Gd-DTPA and Gd-BOPTA for studying renal perfusion and filtration. J Magn Reson Imaging 2011;34:595-607.
59. Henrotte V, Vander Elst L, Laurent S, Muller RN. Comprehensive investigation of the non-covalent binding of MRI contrast agents with human serum albumin. J Biol Inorg Chem 2007;12:929-937.
60. Alford JK, Rutt BK, Scholl TJ, Handler WB, Chronik BA. Delta relaxation enhanced MR: Improving activation - specificity of molecular probes through R1 dispersion imaging. Magn Reson Med 2009;61:796-802.
61. Alford JK, Sorensen AG, Benner T, Chronik AB, Handler BW, Scholl JT, Madan G, Caravan P. Direct protein imaging of inflammation in the human hand. In Proceedings of the 19th Annual Meeting of ISMRM, Montreal, Canada, 2011. Abstract 452.